CRISPR Therapeutics has the potential to generate significant breakthroughs in gene editing. Regeneron's biggest growth ...

Innovations in gene editing, expanding global diagnostic infrastructure, and strong government initiatives are driving the hemoglobinopathies market's projected 11.56% CAGR through 2032, according to ...

The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.

A team of researchers at Columbia, Harvard and University of Minnesota has developed a gene editing technique they say could ...

Cell and gene therapy (C&GT) is set to revolutionise treatment of complex diseases, offering new possibilities for patients.

The gene editing was performed using CRISPR-Cas9 technology and adhered to international biosafety protocols. Importantly, ...

Aligning with EU on genetically modified food and agricultural products will create a regulatory cliffedge for a sector which ...

Intellia has leveraged its expertise in Crispr/Cas9 gene editing to advance a pipeline of in vivo and ex vivo therapies for diseases with high unmet medical needs. We believe Intellia's proprietary ...

An colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a bispecific antibody newly licensed by Pfizer.

Beam Therapeutics faces slow pipeline progress and high R&D costs despite a $500M cash boost. Learn why patience is key for ...